Amazon.com, Inc. (AMZN) Coverage Initiated at Barclays Capital as Equal Weight

Amazon.com, Inc. (AMZN) has been initiated today with coverage from the securities research analysts at Barclays Capital.  Barclays begins this new coverage of AMZN with a performance outlook rating of “equal weight,” Barclays did not provide a price target.  AMZN is trading to the downside during today’s intraday market session.

Amazon is slated to release their next earnings report onJuly 26th, 2011 and the current EPS consensus estimate is 34 cents.  Their last earnings report was released on April 26th, 2011 and announced EPS of 44 with revenue totaling $9.860 billion which was up 38.3 % year to year.  AMZN is currently trading above its 50 & 200-day moving averages and 2011 is currently an up year for the company.

Amazon.com, Inc. began conducting business on the Internet in July 1995 and offers Earth’s Biggest Selection. The company seeks to be Earth’s most customer-centric company for three primary customer sets: consumers, sellers, and enterprises.  Additionally, they generate revenue through other marketing and promotional services, such as online advertising, and co-branded credit card agreements.  The company has market capitalization of $87,336,000,000 and 451,004,000 shares outstanding.  AMZN has a 52-week high of $206.39 with the low being $105.80 dollars.

Latest News

Jazz Pharmaceuticals PLC  Shares Bought by UBS Group AG
Jazz Pharmaceuticals PLC Shares Bought by UBS Group AG
Vina Concha y Toro  Earning Somewhat Negative Media Coverage, Analysis Finds
Vina Concha y Toro Earning Somewhat Negative Media Coverage, Analysis Finds
iShares Edge MSCI USA Value Factor ETF  Shares Bought by UBS Group AG
iShares Edge MSCI USA Value Factor ETF Shares Bought by UBS Group AG
General Electric  To Go Ex-Dividend on June 15th
General Electric To Go Ex-Dividend on June 15th
UnitedHealth Group Inc  to Issue Quarterly Dividend of $0.90 on  June 26th
UnitedHealth Group Inc to Issue Quarterly Dividend of $0.90 on June 26th
Oxford Immunotec Global  Rating Lowered to Buy at BidaskClub
Oxford Immunotec Global Rating Lowered to Buy at BidaskClub


© 2006-2018 Ticker Report. Google+.